Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022

Latest Articles

  • You have access
    Infections in primary vasculitides
    J.W. Cohen Tervaert, MD, PhD
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-24-SII-26;
  • You have access
    Statins and osteoporosis: Can these lipid-lowering drugs also bolster bones?
    Abelardo C. Cruz, MD and Barry L. Gruber, MD
    Cleveland Clinic Journal of Medicine April 2002, 69 (4) 277-288;

    Statin drugs may promote bone formation. Although the clinical data are limited and mixed, they may point the way to better drugs for osteoporosis.

  • You have access
    Increases of PR3 and MPO Gene Transcription in Circulating Leukocyte of Anca-Associated Disease Correlate with Disease Activity
    JJ Yang, GA Preston, DA Alcorta, BD Phillips, RP Thomas, SL Hogan, JC Jennette and RJ Falk
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-103;
  • You have access
    Developing an economic rationale for the use of selective COX-2 inhibitors for patients at risk for NSAID gastropathy
    A. Mark Fendrick, MD
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 1) SI-59-SI-64;
  • You have access
    Genetic Resistance to Wegener’s Granulomatosis—A Role for CCR5 in Patients Without Antineutrophil Cytoplasmic Antibodies
    Y Zhou, D Huang, C Farver and G Hoffman
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-44;
  • You have access
    Endothelial Microparticles: Just Blood “Dust,” or a “Must” for the Diagnosis and Monitoring of Disease Activity in Childhood Vasculitides?
    PA Brogan, V Shah, C Brachet, N Klein and MJ Dillon
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-103-SII-104;
  • You have access
    Author Index
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-193-SII-196;
  • You have access
    Sudden weakness in a patient with lymphoma
    Andrew Naidech, MD, MSPH, Sarala Palliyath, MD, Leon Weisberg, MD and Marc Kahn, MD
    Cleveland Clinic Journal of Medicine April 2002, 69 (4) 337-341;

    What is the cause of this patient’s symptoms? A self-test.

  • You have access
    Diagnostic Modalities, Surrogate Markers of Disease Activity, and Tools for Outcome Measurements
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-171-SII-179;
  • You have access
    Development and clinical application of COX-2–selective inhibitors for the treatment of osteoarthritis and rheumatoid arthritis
    Clifton O. Bingham, MD
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 1) SI-5-SI-12;

Pages

  • Previous
  • Next
  • 1
  • …
  • 388
  • 389
  • 390
  • 391
  • 392
  • 393
  • 394
  • 395
  • 396
  • …
  • 799

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire